-Advertisement-
Ocular Surface Disease
![](https://ophthalmology360.com/wp-content/uploads/2022/08/AdobeStock_251395669-scaled.jpeg)
Bausch + Lomb boosts diagnostic capabilities with acquisition of Trukera Medical
Bausch + Lomb Corporation announced the acquisition of Trukera Medical, a United States-based ophthalmic medical diagnostic company, according to a press release. Trukera Medical, previously owned by AccelMed Partners and other shareholders, is known for its ScoutPro device, which measures the osmolarity of tears, a key indicator of dry eye...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Videos
11 Jul, 2024
Eric Donnenfeld, MD, ophthalmologist at OCLI Vision, clinical professor of...
-Advertisement-
-Advertisement-
Contact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved